Growth hormone insulin-like growth factor i axis in insulin-dependent diabetes mellitus

Hormone Research in Paediatrics

Volumn 46, Issue 1, 1996, Pages 2-6

  Dunger, D B ^a   Cheetham, T D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adolescence; Growth hormone; Insulin dependent diabetes mellitus; Recombinant human insulin like growth factor I

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADOLESCENT; DIABETIC MICROANGIOPATHY; GROWTH RETARDATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; METABOLIC REGULATION; PRIORITY JOURNAL; PUBERTY; RISK; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0029758665     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184969     Document Type: Article

References (49)

1. Drash AL: The child, the adolescent and the Diabetes Control and Complications Trial, Diabetes Care 1993:16:1515-1516.
2. Edge JA, Dunger DB, Matthews DR, Gilbert JR, Smith CP: Increased overnight growth hormone concentrations in diabetic compared with normal adolescents, J Clin Endocrinol Metab 1990:71:1356-1362.
3. Asplin CM, Faria ACS, Carlsen EC, et al: Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus, J Clin Endocrinol Metab 1989;69:239-245.
4. Batch JA, Werther GA: Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes, Clin Endocrinol (Oxf) 1992:36:411-416.
5. Mullis PE, Pal BR, Matthews DR, Hindmarsh PC, Phillips PE, Dunger DB: Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type 1 (insulin-dependent) diabetes mellitus, Clin Endocrinol (Oxf) 1992;36: 255-263.
6. Pal BR, Matthews DR, Edge JA, Mullis PE, Hindmarsh PC, Dunger DB: The frequency and amplitude of growth hormone secretory episodes as determined by deonvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short term euglycaemia, Clin Endocrinol (Oxf) 1993,38:93-100.
7. Amiel SA, Shcrwin RS, Hintz RL, Gcrtner JM, Press M, Tantborlane WV: Effects of diabetes and its control on insulin-like grow th factors in the young subject with type 1 diabetes, Diabetes 1984:33:1175-1179.
8. Taylor AM, Dunger DB, Grant DB, Preece MA: Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents w ith insulin dependent diabetes mellitus compared with puberty matched controls, Diabetes Res 1988:9:177-181.
9. Yde H: The growth hormone dependent sul-phation factor in serum from patients with various types of diabetes, Acta Med Scand 1969: 186:293-297.
10. Batch JA, Baxter RC, Werther G: Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes, J Clin Endocrinol Metab 1991:73: 964-968.
11. Clayton KJL, Holly JMP, Carlsson LMS, Jones J, Chectham TD, Taylor AM, Dunger DB: Loss of the normal relationships between growth hormone, growth hormone binding protein and insulin-like growth factor-1 in adolescents with insulin dependent diabetes mellitus, Clin Endocrinol (Oxf) 1994:41:517-524.
12. Massa G, Dooms L, Bouillon R, Vanderschuren-Lodeweyckx M: Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus, Diabetologia 1993:36:239-243.
13. Mcnon RK, Arslanian S, May B, Cutfield WS, Sperling MA: Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus, J Clin Endocrinol Metab 1992:74:934-938.
14. Lanes R, Recker B, Fort P, Lifshitz F: Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus, Diabetes 1985;34:156-160.
15. Baxter RX, Turtle JR: Regulation of hepatic growth hormone receptors by insulin, Biochcnt Biophys RcsCommun 1978;84:350-357.
16. Daughaday WH, Phillips LS, Mueller MS: The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver, Endocrinology 1976;98:1214-1219.
17. Maes M, Underwood LE, Ketclslegers J-M: Low scrum somatomedin-C in insulin-dependent diabetes: Evidence for a post receptor mechanism, Endocrinology 1986:118:377-382.
18. Arslanian SA, Mcnon RK, Gierl AP, Heil BV, Foley TP Jr.: Insulin therapy increases low' plasma growth hormone binding protein in children with new onset type 1 diabetes, Diabetic Med 1993;10:833-838.
19. Holly JMP, Biddlccombe RA, Dunger DB, Edge JA, Amiel SA, Howell R, Chard T, Rees LH, Wass JAH: Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin: A new role for insulin? Clin Endocrinol (Oxf) 1988: 29:667-675.
20. Sui K, Kari AM, Kovisto VA, Rulanen EM, Yki Jarvinen H, Karonen S-L, Seppala M: Insulin regulates the serum levels oflow molecular weight insulin-like growth factor-binding protein, J Clin Endocrinol Metab 1988:66: 266-272.
21. Cotterill AM, Cowell CJ, Silink M: Insulin and variation in glucose levels modify the secretion rates of growth hormone independent insulinlike growth factor binding protein-I in the human hepatoblastoma cell line Hep G2, Endocrinology 1989; 123:R17.
22. Holly JMP, Dunger DB, Edge JA, Smith CP, Chard T, Wass JAH: Insulin-like growth factor binding protein-1 (1GFBP-I) levels in diabetic adolescents and their relationship to metabolic control, Diabetic Med 1990;7:618-623.
23. Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JAH, Patel S, Tate VE: The growth hormone independent insulin-like growth factor-1 binding protein BP-28 is associated with serum insulin-like growth lactor-l inhibitory' bioactivity in adolescent insulin dependent diabetes, Clin Endocrinol (Oxf) 1990: 32:229-239.
24. Brisntar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-I (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes, J Clin Endocrinol Metab 1994;79:872-878.
25. Wurzburger ML Prevelic GM, Sonksen PH, Balint-Pcric LA, Wheeler M: The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes, J Clin Endocrinol Metab 1993;77:267-272.
26. Chccthani TD, Clayton KL, Taylor AM, Holly JMP, Malthcw DR, Dünger DB: The elTects ol' recombinant human insulin-likc growth factor I (rhIGF-I) on growth hormone secretion in adolescents with insulin dependent diabetes mellitus, Clin Endocrinol (Oxf) 1994:40:515-522.
27. Press M, Taborlanc WV, Shenvin RS: Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes, N Engl J Med 1984:310:810-815.
28. Edge JA, Pal BR, Harris DA, Matthews DR, Phillips PE, Dünger DB: Evidence for a role for insulin and growth hormone in the overnight regulation of ß-hydroxybutyrate in normal and diabetic adolescents, Diabetes Care 1993:16: 1011-1018.
29. Pal BR, Philips PE, Matthews DR, Dünger DB: Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with insulin-dependent diabetes mellitus, Diabctologia 1992:35:542-549.
30. Beaufrcre B, Bcylot M, Metz C, Rcutton A, Francois R, Riou JP, Mermex R: Dawn phenomenon in type I (insulin-dependent) diabetic adolescents: Influence of nocturnal growth hormone secretion, Diabetologia 1988:31:607-611.
31. Edge JA, Matthews DR, Dunger DB: The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics, Clin Endocrinol (Oxf) 1990:33:729-737.
32. Chcclham TD, Jones J, Taylor AM, Holly JMP, Matthews DR, Dunger DB: The effects of recombinant insulin-like growth factor-I administration on growth hormone levels and insulin requirements in adolescents with type I (insulin-dependent) diabetes mellitus, Diabctologia 1993;36:678-681.
33. Bach MA, Chin E, Bondv CA: The effects of subcutaneous insulin-likc growth factor-I infusion in insulin-dependent diabetes mellitus, J Clin Endocrinol Metab 1994;79:1040-1045.
34. Dimitriadis G, Parry-Billings M, Piva T, Dunger DB, Bevan S, Wegener G, Krause U, News-holme E: Effects of insulin-like growth factor I on the rates of glucose transport and utilisation in rat skeletal muscle in vitro, Biochcm J 1992; 285:269-274.
35. Lewitt MS, Dcnycr GS, Cooney GJ, Baxter RC: Insulin-like growth factor binding protein-I modulates blood glucose levels, Endocrinology 1991;129:2254-2256.
36. Crowne EC, Samru J, Holly J, Cheetham T, Dunger DB: Administration of rhlGF-l and GH prevents GH-induccd changes in insulin sensitivity in IDDM, Hornt Res 1995:44 (suppl 0):79.
37. Rudolf MCJ, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadl J, et al: Effect of intensive insulin treatment on linear growth in the young diabetic patient, J Pediatr 1982:101: 333-339.
38. Edge JA, Matthews DR, Dunger DB: Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes, Diabetes Res 1990; 15:109-112.
39. Whincup G, Milner RDG: Prediction and management of nocturnal hypoglycacmia in diabetes, Arch Dis Child 1987:62:333-337.
40. Greene SA, Smith MA, Baum JD: Clinical applications of insulin pumps in the management of insulin dependent diabetes, Arch Dis Child 1983;58:578-581.
41. Arias P, Kemer W, de la Fuenta A, Pfeiffer EF: Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified insulin treatment, Acta Endocrinol (Copetih) 1984;107:250-255.
42. Hcrmansen K, Moller A, Christiansen CK, Christiansen JS, Schmitz O, Orskov H, Alberti KGGM, Mogcnsen CF.: Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion, Acta Endocrinol (Copenh) 1987; 114:433-439.
43. Press M, Caprio S, Tamborlane WV, Bhushan R, Thomcr M, Vale W, Rivier J, Shenvin RS: Pituitary response to growth hormone-releasing hormone in IDDM: Abnormal responses to insulin and hypcrglycaemia, Diabetes 1992:41: 17-21.
44. Shisko PI, Kovaler PA, Goncharov VG, Zajar-ny IU: Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients, Diabetes 1992:41: 1042-1049.
45. Cheetham TD, Taylor AM, Holly JMP, Clayton K, Cwyfan-Hughes S, Dunger DB: The effects of recombinant human insulin-like growth factor-I (rhIGF-I) administration on the levels of 1GF-I, IGF-II and IGF binding proteins in adolescents with insulin-dependent diabetes mellitus, J Endocrinol 1994; 142:367-374.
46. Cheetham TD, Holly JMP, Clayton K, Curtan-Hughes S, Dunger DB: The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes, Diabetic Med 1995:12:885-892.
47. Jabri N, Schalch DS, Schwartz SL, Fischer JS, Kipncs MS, Radnik BJ, Turman NJ, Marcsisin VS, Guler H-P: Adverse effects of recombinant human insulin-like growth factor I in obese insulin resistant type 11 diabetic patients, Diabetes 1994:43:369-374.
48. Gerich JE: Role of growth hormone in diabetes mellitus, N Engl J Med 1984:310:848-850.
49. Dills DG, Moss SE, Klein R, Klein BEK, Davis M: Is insulin-likc growth factor 1 associated with diabetic retinopathy? Diabetes 1990:39: 191-195.